Folic acid-modified Exosome-PH20 enhances the efficiency of therapy via modulation of the tumor microenvironment and directly inhibits tumor cell metastasis

• Published in: Bioactive materials 2021-04, Vol.6 (4), p.963-974
• Main Authors: Feng, Chunxiang, Xiong, Zhiyong, Wang, Cheng, Xiao, Wen, Xiao, Haibing, Xie, Kairu, Chen, Ke, Liang, Huageng, Zhang, Xiaoping, Yang, Hongmei
• Format: Article
• Language: English
• Subjects: Exosomes; Hyaluronidase; Metastasis; Tumor immunotherapy; Tumor microenvironment
• ISSN: 2452-199X; 2452-199X
• DOI: 10.1016/j.bioactmat.2020.09.014

High accumulation of hyaluronan (HA) in the tumor microenvironment leads to an increase in the interstitial pressure and reduction perfusion of drugs. Furthermore, high molecular-weight (HMW)-HA suppresses M1 macrophage polarization, enhances M2 polarization, and induces immunosuppression. Hyaluronidase treatment have attempted to decrease the quantity of HA in tumors. However, hyaluronidase-driven HA degradation driven accelerates tumor cell metastasis, which is a major cause of mortality in cancer patients. Thus, we designed a novel exosome-based drug delivery system (DDS), named Exos-PH20-FA, using genetic engineering to express human hyaluronidase (PH20) and self-assembly techniques to modify the exosomes with folic acid (FA). Our results show that Exos-PH20-FA degraded HMW-HA to low-molecular-weight (LMW)-HA. Moreover, LMW-HA polarized macrophages to the M1 phenotype and reduced the number of relevant immunosuppressive immunocytes which changed the immune microenvironment from an immunosuppressive to immunosupportive phenotype. Furthermore, we demonstrated Exos-PH20-FA directly reduced hyaluronidase-induced metastasis of tumor cells. This tumor treatment also allowed an enhanced delivery of chemotherapy by tumor-targeting effect with FA modification. Our findings indicate that Exos-PH20-FA improves tumor treatment efficiency and reduces the side effects of hyaluronidase treatment, namely tumor cell metastasis. This all-in-one exosome-based HA targeting DDS maybe a promising treatment that yields more efficient and safer results. •High molecular-weight hyaluronan is related to tumor progression.•The degradation of hyaluronan enhance cancer cell migration and metastasis.•Folic acid can target tumor and inhibit tumor cell migration.•Exosomes are ideal carriers for chemotherapeutics, folic acid and hyaluronidase.